Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q15131
UPID:
CDK10_HUMAN
Alternative names:
Cell division protein kinase 10; Serine/threonine-protein kinase PISSLRE
Alternative UPACC:
Q15131; A8K370; A8K8I6; A8MXU6; B3KQJ3; B7Z420; D3DX82; D3DX83; Q0VGZ7; Q15130; Q6PJC0
Background:
Cyclin-dependent kinase 10 (CDK10), also known as Serine/threonine-protein kinase PISSLRE, plays a pivotal role in cell division and the regulation of the actin cytoskeleton. It is known for phosphorylating the transcription factor ETS2, which influences its degradation, and for its involvement in actin dynamics through the phosphorylation of PKN2. CDK10's activity is crucial for the negative regulation of ciliogenesis, promoting RhoA signaling.
Therapeutic significance:
CDK10 is linked to Al Kaissi syndrome, a disorder marked by growth retardation, spine malformation, and developmental delays, due to gene variants affecting CDK10. Understanding the role of CDK10 could open doors to potential therapeutic strategies for this syndrome.